中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:( Qiangqiang LU)

1.Hardware Implementation of Numerical Simulation Function of Hodgkin-Huxley Model Neurons Action Potential Based on Field Programmable Gate Array.

Jinlong WANG ; Mai LU ; Yanwen HU ; Xiaoqiang CHEN ; Qiangqiang PAN

Journal of Biomedical Engineering 2015;32(6):1302-1309

2.Efficacy and Safety of Rivaroxaban on Thrombotic Disease Prevention in Very Elderly Patients

Yu DING ; Kun XU ; Quanjin SI ; Qiangqiang LU

Chinese Circulation Journal 2017;32(8):788-791

3.Prevalence of ametropia and visual impairment in elementary school students in Baoshan District of Shanghai

xiaofeng, ZHU ; Jianfeng, ZHU ; Haidong, ZOU ; Lina, LU ; Huijuan, ZHAO ; Qiangqiang, LI ; Xiangui, HE

Chinese Journal of Experimental Ophthalmology 2014;32(5):451-456

4.CT-guided percutaneous removal of osteoid osteoma.

Jian-qiang XU ; Wei-bin ZHANG ; Cai-wei SHEN ; Xiao-yi DING ; Yong LU

Chinese Journal of Surgery 2005;43(16):1063-1065

5.Expert consensus on the diagnosis and treatment of cryptococcal meningitis

Zhengyin LIU ; Guiqiang WANG ; Liping ZHU ; Xiaoju LYU ; Qiangqiang ZHANG ; Yunsong YU ; Zhihui ZHOU ; Yanbin LIU ; Weiping CAI ; Ruoyu LI ; Wenhong ZHANG ; Fujie ZHANG ; Hao WU ; Yingchun XU ; Hongzhou LU ; Taisheng LI

Chinese Journal of Internal Medicine 2018;57(5):317-323

6.Role of miR-144-3p and its target gene in regulating osteogenic differentiation of rat bone marrow mesenchymal stem cells .

Jin LU ; Haoxuan ZHANG ; Peng YU ; Yifeng GONG ; Xiwang GONG ; Qiangqiang FAN ; Yue YANG

Journal of Southern Medical University 2018;38(9):1083-1088

7.A Meta-Analysis of Efficacy and Adverse Effects of Lobaplatin and Cisplatin in the Treatment of Malignant Pleural Effusion.

Shihui MIN ; Qiangqiang ZHENG ; Bailu ZHANG ; Danli YAN ; Rulan WANG ; Zihan QU ; Lu LI ; Jiewei LIU ; Qinghua ZHOU

Chinese Journal of Lung Cancer 2019;22(2):90-98

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO